書名 : Coherence for health :innovation for new medicines for infectious diseases.
紀錄類型 : 書目-語言資料,印刷品: 單行本
正題名[資料類型標示]/作者 : Coherence for health :
其他題名 : innovation for new medicines for infectious diseases.
團體作者 : Organisation for Economic Co-operation and Development.
出版者 : Paris :OECD,c2009.
面頁冊數 : 147 p. ;23 cm.
附註 : "[This publication] brings together the report, outcomes and background papers for the High-Level Forum on Policy Coherence: Availability of Medicines for Neglected and Emerging Infectious Diseases (HLF), held in June 2007 in Noordwijk-aan-Zee, Netherlands"--P. 4.
內容註 : Neglected and emerging infectious diseases : why it is an issue now -- What are the problems? : why is it in the economic interest of OECD countries to address these problems? -- Present policy solutions being used to address the problems of neglected infectious diseases -- Moving forward : solutions and next steps.
標題 : Pharmaceutical policy
ISBN : 9789264060142
集叢項 : The developement dimension
LEADER 01919cam 2200277 a 45 0
001 306134
003 TNML
005 20130813104427.0
008 090510s2009 fr b 1|| | eng c
020 $a9789264060142
020 $a9264060146
020 $a9789264060166 (pdf)
020 $a9264060162 pdf)
035 $a(OCoLC)320803814
035 $a772140
040 $aBTCTA$beng$cSTF$dBTCTA$dDLC$dYDXCP$dNLM$dTWTNM
050 4$aRA401.A1$bH53 2007
082 00$a338.4$222
111 2 $aHigh-Level Forum on Policy Coherence: Availability of Medicines for Neglected and Emerging Infectious Diseases$d(2007 :$cNoordwijk aan Zee, Netherlands)
245 10$aCoherence for health :$binnovation for new medicines for infectious diseases.
260 $aParis :$bOECD,$cc2009.
300 $a147 p. ;$c23 cm.
490 1 $aThe developement dimension
500 $a"[This publication] brings together the report, outcomes and background papers for the High-Level Forum on Policy Coherence: Availability of Medicines for Neglected and Emerging Infectious Diseases (HLF), held in June 2007 in Noordwijk-aan-Zee, Netherlands"--P. 4.
504 $aIncludes bibliographical references.
505 2 $aNeglected and emerging infectious diseases : why it is an issue now -- What are the problems? : why is it in the economic interest of OECD countries to address these problems? -- Present policy solutions being used to address the problems of neglected infectious diseases -- Moving forward : solutions and next steps.
520 $aIn developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organization. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development cooperation and finance.--Publisher's description.
530 $aAlso issued electronically via World Wide Web.
650 0$aPharmaceutical policy$vCongresses.
650 0$aDrug development$vCongresses.
650 0$aCommunicable diseases$zDeveloping countries$vCongresses.
650 0$aPharmaceutical industry$vCongresses.
650 12$aAnti-Infective Agents$xeconomics$vCongresses.
650 22$aCommunicable Diseases$xdrug therapy$vCongresses.
650 22$aCommunicable Diseases$xeconomics$vCongresses.
650 22$aDeveloping Countries$vCongresses.
650 22$aDrug Industry$vCongresses.
650 22$aSocioeconomic Factors$vCongresses.
710 2 $aOrganisation for Economic Co-operation and Development.
830 0$aDevelopment dimension.